3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
5
Lung Neoplasms
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Multiple Myeloma
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Support of the Family as a Caregiving System
1
Stomach Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Otorhinolaryngologic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Mixed Dementias
1
Meningeal Carcinomatosis
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Follicular
1
Localized Head and Neck Carcinoma
1
Lewy Body Disease
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Disease
1
Dementia, Vascular
1
Dementia
1
Cognitive Dysfunction
1
Cigarette Smoking-Related Carcinoma
1
Cardiovascular Diseases
1
Interventions
Pemetrexed
8
Spinal Puncture
5
Specimen Handling
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
aflutinib
3
Trastuzumab
3
Bevacizumab
3
trastuzumab deruxtecan
2
pembrolizumab
2
osimertinib
2
Radiotherapy, Intensity-Modulated
2
tucatinib
1
toripalimab
1
sintilimab
1
sacituzumab govitecan
1
pertuzumab
1
peginterferon alfa-2b
1
lorlatinib
1
lenvatinib
1
azeliragon
1
avelumab
1
adavosertib
1
Temozolomide
1
Referral and Consultation
1
Radiosurgery
1
Radiation
1
Probability
1
Physical Examination
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
Referral and Consultation
×
1 year
×
Clear all
NCT05286684
2026-03-18
Exo-LCR
Centre Oscar Lambret
Phase NA
Completed
7 enrolled